Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] ALTEOGEN (196170) – (Correction) Decision on Bonus Issue / 2026-07-20

Posted on July 20, 2026August 5, 2026 By K-STOCK Editor No Comments on [Disclosure] ALTEOGEN (196170) – (Correction) Decision on Bonus Issue / 2026-07-20

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

ALTEOGEN submitted a correction disclosure updating the expected listing date of new shares for its bonus issue from August 20, 2026, to August 26, 2026, following consultations with relevant authorities.

📊 [Key Disclosure Details & Major Figures Summary]

  • Filing Type: Corrected Filing (Original Filing Date: July 16, 2026)
  • Reason for Correction: Change in expected listing date of new shares due to consultations with relevant authorities
  • Correction Details (Expected Listing Date of New Shares):
    • Before Correction: August 20, 2026
    • After Correction: August 26, 2026
  • Key Details of Bonus Issue (Maintained as Original):
    • Type & Number of New Shares: 16,068,790 Common Shares, 122,037 Other Shares (Redeemable Convertible Preferred Stock) (Total 16,190,827 shares)
    • Par Value per Share: KRW 500
    • New Shares Allotted per Share: 0.3 new shares per 1 share for Common and Other Shares (30% allotment ratio)
    • Record Date for Allotment: August 06, 2026
    • Dividend Base Date for New Shares: January 01, 2026
    • Capital Source: Capital Surplus of KRW 8,095,413,500 (Approx. KRW 8.10B)
    • Fractional Share Treatment: Fractional shares under 1 full share paid in cash based on the closing price on the first listing day
    • Shares Excluded from Allotment: 23,708 Treasury Shares (Common Stock)
  • Board Resolution Date: July 16, 2026 (4 Independent Directors attended, Auditor attended)

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Execution on the Revised Expected Listing Date

This correction disclosure updates the expected listing date for bonus issue new shares to August 26, 2026. Verifying that the listing procedure is executed as scheduled on the revised listing date is essential because it allows investors to confirm that the revised capital increase timeline is completed as planned. Detailed updates can be cross-checked in subsequent disclosure filings and periodic reports (Quarterly, Half-Yearly, and Annual Reports).

📢 Disclaimer & Source Notice

Source: This content has been structured and newly created based on official filing data from the Financial Supervisory Service (DART).

Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Samsung Biologics (207940) – Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2026-07-20
Next Post: [Disclosure] Daeduck Electronics (353200) – New Facility Investment / 2026-07-20

Related Posts

[Disclosure] Samsung Electro-Mechanics (009150) – Change in Revenue or Financial Structure Exceeding 30% (15% for Large Corporations) / 2026-01-23 Semiconductors
[Disclosure] Samsung Electronics (005930) – Change in CEO (Notice Disclosure) / 2025-03-25 Semiconductors
[Disclosure] Hanwha Ocean (042660) – (Correction) Sales and Supply Contract / 2025-06-18 Disclosures
[Disclosure] Hanmi Semiconductor (042700) – Decision on Termination of Trust Contract for Treasury Stock Acquisition / 2024-10-23 Semiconductors
[Disclosure] Celltrion (068270) – Forward-Looking Business and Management Plan (Fair Disclosure) / 2024-11-27 Disclosures
[Disclosure] ISU PETASYS (007660) – Paid-in Capital Increase (Correction) / 2024-11-14 Semiconductors

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme